Physician profile
David E Rentz
NPI 1366468621
$931.08
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $87.61 · 2021: $55.28 · 2022: $129 · 2023: $91.49 · 2024: $214 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $154.07 | 2019-2025 | |
| Gilead Sciences, INC. | $151.65 | 2022-2025 | Veklury |
| Janssen Pharmaceuticals, INC | $146.37 | 2019-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.18 | 2023-2025 | Xifaxan |
| Grifols USA, LLC | $73.09 | 2024-2025 | Hyperrab |
| Abbvie INC. | $64.19 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $59.42 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $44.57 | 2019-2022 | |
| Stryker Corporation | $40.26 | 2025 | Flowtriever |
| Allergan, INC. | $38.33 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $33.17 | 2019 | |
| Csl Behring | $20.50 | 2020 | |
| Melinta Therapeutics, LLC | $18.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rentz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.